Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation∗∗The investigators and institutions participating in the study are listed in the Appendix.
Authors:
- Vittorio PengoVPVittorio Pengo
- Antonella ZassoAZAntonella Zasso
- Fabio BarberoFBFabio Barbero
- Alberto BanzatoABAlberto Banzato
- Giovanni NanteGNGiovanni Nante
- Lucia ParissentiLPLucia Parissenti
- Nancy JohnNJNancy John
- Franco NoventaFNFranco Noventa
- Sergio Dalla VoltaSVSergio Dalla Volta
- 1 August 1998
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (4) , 433-437
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- An Analysis of the Lowest Effective Intensity of Prophylactic Anticoagulation for Patients with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1996
- Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerThe Lancet, 1994
- Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1992
- Stroke Prevention in Atrial Fibrillation Study. Final results.Circulation, 1991
- Canadian atrial fibrillation anticoaguiation (CAFA) studyJACC, 1991
- The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1990
- Very Low Doses of Warfarin Can Prevent Thrombosis in Central Venous CathetersAnnals of Internal Medicine, 1990
- Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery.BMJ, 1987
- Cardiogenic Brain EmbolismArchives of Neurology, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958